This website is intended for healthcare professionals only

Trending Topic

Comprehensive Anatomical Render Of Breast Cancer In A Human Female
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Circulating tumor DNA (ctDNA) has emerged as an innovative and minimally invasive tool in precision oncology. With a short half-life of 30–120 min, ctDNA provides real-time insight into tumor dynamics.1 In early-stage breast cancer, there is growing evidence supporting its potential for minimal residual disease (MRD) detection and recurrence monitoring. In metastatic breast cancer (MBC), ctDNA […]

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 26th 2021

Co-Chair of the European Cancer Organisation’s Impact of COVID-19 on Cancer Special Network, Prof. Mark Lawler (Queen’s University, Belfast, UK) speaks to touchONCOLOGY about the impact the COVID-19 pandemic has had on cancer care and the newly launched ‘Time to Act’ campaign. Further information about the campaign can be found on the European Cancer Organisation’s website at https://www.europeancancer.org/timetoact.

Questions

  1. How has the COVID-19 pandemic impacted on cancer care across Europe? (0:18)
  2. Could you tell us a little about the ‘Time to Act’ campaign and its objectives? (1:04)
  3. What advice has the European Cancer Organisation given to governments? (2:24)
  4. What are the major obstacles to addressing the current unmet needs in cancer care and how can they be overcome? (3:02)

Disclosures: Unrestricted educational grant from Pfizer for research unrelated to this work. Honoraria from Pfizer, EMD Serono , Roche and Carnall Farrar unrelated to this work.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Helen Fowler.

 

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup